At Flora, we believe the future of the cannabis industry lies in the ability to bring products and medications to communities around the globe. We are accomplishing this through worldclass natural farming and manufacturing, thoughtful brands that reach consumers in every corner of the market and through the rigorous research and development of medicalgrade products that patients can trust.
We have the team, go-to-market leadership and playbook, brand expertise, research and technology, supply chain, and pathway to become the leader on the international cannabis stage.
At Flora Growth, we are seeking to build the next generation of cannabis company. Our aim is strategic, global growth leveraging our high-quality commercial cannabis and state-of-the-art transformation laboratories, our dynamic house of brands, and our work in the life sciences sector to bring quality cannabis to the world.
FORT LAUDERDALE, FLORIDA & TORONTO, May 24, 2023 – – Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a global cultivator, manufacturer, and distributor of cannabis products and
Flora generated $20.1 million in revenue in Q1 2023, a 307% increase year-over-year. Gross profit for Q1 2023 increased 105% year-over-year, to $5.5 million. Posting a net loss of
FORT LAUDERDALE, FLORIDA– April 18, 2023 – Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”) a leading cultivator, manufacturer and distributor of global cannabis products and brands, today announced
